M. Duro

Impact on Survival of Timing and Duration of Adjuvant Chemotherapy in Radically Resected Gastric Cancer

R. Todeschini, M. Pirovano, S. Barni, 2016, Tumori.

Thrombosis-related complications and mortality in cancer patients with central venous devices: an observational study on the effect of antithrombotic prophylaxis.

C. Porta, C. Cimminiello, R. Franchi, 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

High- versus low-dose levo-leucovorin as a modulator of 5-fluorouracil in advanced colorectal cancer: A ‘GISCAD’ phase III study

S. Barni, R. Labianca, L. Frontini, 1997 .

A classification prognostic score to predict OS in stage IV well-differentiated neuroendocrine tumors

H. Comber, L. Mariani, V. Mazzaferro, 2018, Endocrine-related cancer.

A randomized trial of intensive versus minimal surveillance of patients with resected Dukes B2-C colorectal carcinoma.

S. Barni, R. Labianca, E. Negri, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Colorectal Cancer With Low-dose Interferoma2b and Folinic Acid. The "GISCAD" Experience

S. Barni, R. Labianca, G. Martignoni, 1994 .

Double modulation of 5-fluorouracil in advanced colorectal cancer with low-dose interferon-α2b and folinic acid. The “GISCAD” experience

S. Barni, R. Labianca, G. Luporini, 1994 .

Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues.

V. Mazzaferro, S. Ricci, F. di Costanzo, 2018, Gastroenterology.

High-versus low-dose levo-leucovorin as a modulator of 5-fluorouracil in advanced colorectal cancer: a 'GISCAD' phase III study. Italian Group for the Study of Digestive Tract Cancer.

S. Barni, R. Labianca, G. Luporini, 1997, Annals of Oncology.